Skip to main content
. 2023 May 17;24:338. doi: 10.1186/s13063-023-07306-z
Regulatory Date

Approval of legal authority:

Bundesamt für Arzneimittel und Medizinprodukte

05/19/2017
Approval ethics committee 07/06/2017
1st data and safety monitoring board meeting 06/26/2017
1st patient in 08/07/2017
App. end of recruitement QII/2023
Study duration 48 months of follow-up